SK Chemicals to release new gout medication

SK Chemicals announced on July 2 that it received the marketing approval of Febuxostat 80 mg (brand name: Feburic), an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and gout, by the Korea Food and Drug Administration.

The company is expected to launch the drug in the first half of next year, when its insurance price is available through negotiation...